147 related articles for article (PubMed ID: 1534701)
21. Paramesangial glomerular deposits in membranoproliferative glomerulonephritis type II correlate with hypocomplementemia.
West CD; McAdams AJ
Am J Kidney Dis; 1995 Jun; 25(6):853-61. PubMed ID: 7771481
[TBL] [Abstract][Full Text] [Related]
22. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.
Sethi S; Fervenza FC
Semin Nephrol; 2011 Jul; 31(4):341-8. PubMed ID: 21839367
[TBL] [Abstract][Full Text] [Related]
23. [Comparative characteristics of morphologic types of mesangiocapillary glomerulonephritis (morphologic correlation analysis)].
Severgina LO
Arkh Patol; 1994; 56(3):63-5. PubMed ID: 8092945
[TBL] [Abstract][Full Text] [Related]
24. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
[TBL] [Abstract][Full Text] [Related]
25. Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.
Varade WS; Forristal J; West CD
Am J Kidney Dis; 1990 Sep; 16(3):196-206. PubMed ID: 2205097
[TBL] [Abstract][Full Text] [Related]
26. Infantile immunoglobulin A nephropathy showing features of membranoproliferative glomerulonephritis.
Kurosu A; Oka N; Hamaguchi T; Yoshikawa N; Joh K
Tohoku J Exp Med; 2012 Nov; 228(3):253-8. PubMed ID: 23089637
[TBL] [Abstract][Full Text] [Related]
27. Mesangiocapillary glomerulonephritis in Down's syndrome.
Gupta SK; Venkataseshan VS; Churg J
Am J Nephrol; 1991; 11(2):112-7. PubMed ID: 1835296
[TBL] [Abstract][Full Text] [Related]
28. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis.
Cansick JC; Lennon R; Cummins CL; Howie AJ; McGraw ME; Saleem MA; Tizard EJ; Hulton SA; Milford DV; Taylor CM
Nephrol Dial Transplant; 2004 Nov; 19(11):2769-77. PubMed ID: 15385635
[TBL] [Abstract][Full Text] [Related]
29. Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy.
Martinelli R; Noblat AC; Brito E; Rocha H
Kidney Int; 1989 May; 35(5):1227-33. PubMed ID: 2504987
[TBL] [Abstract][Full Text] [Related]
30. Short-term outcome of clinical and histopathologic variants of mesangiocapillary glomerulonephritis in children: A retrospective analysis from a tertiary care center.
Khatri S; Bajeer IA; Tresa V; Hashmi S; Mubarak M; Lanewala AA
J Pak Med Assoc; 2018 Aug; 68(8):1199-1204. PubMed ID: 30108386
[TBL] [Abstract][Full Text] [Related]
31. Histopathological atlas of renal diseases. Membranoproliferative glomerulonephritis.
Ferrario F; Rastaldi MP
J Nephrol; 2004; 17(4):483-6. PubMed ID: 15372408
[TBL] [Abstract][Full Text] [Related]
32. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
Ito S; Kuriyama H; Iino N; Iguchi S; Shimada H; Ueno M; Narita I; Nakano M; Nishi S; Karasawa R; Gejyo F
Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
[TBL] [Abstract][Full Text] [Related]
33. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome?
Davenport A; Maciver AG; Mackenzie JC
Nephrol Dial Transplant; 1992; 7(5):391-6. PubMed ID: 1321373
[TBL] [Abstract][Full Text] [Related]
34. [Clinico-morphologic comparisons in mesangiocapillary glomerulonephritis].
Plotkin VIa
Vrach Delo; 1989 Oct; (10):43-6. PubMed ID: 2617981
[TBL] [Abstract][Full Text] [Related]
35. Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis.
Dash SC; Bhuyan UN; Dinda AK; Saxena S; Agarwal SK; Tiwari SC; Nundy S
Kidney Int; 1997 Aug; 52(2):482-5. PubMed ID: 9264006
[TBL] [Abstract][Full Text] [Related]
36. Mesangiocapillary glomerulonephritis caused by Puumala hantavirus infection.
Mustonen J; Mäkelä S; Helin H; Helanterä A; Miettinen M; Partanen J; Pasternack A
Nephron; 2001 Dec; 89(4):402-7. PubMed ID: 11721157
[TBL] [Abstract][Full Text] [Related]
37. Dense intramembranous deposit disease: new pathologic features.
Sibley RK; Kim Y
Kidney Int; 1984 Apr; 25(4):660-70. PubMed ID: 6482170
[TBL] [Abstract][Full Text] [Related]
38. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
Davis BK; Cavallo T
Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis in lupus SLE-N IV and non-lupus mesangiocapillary glomerulonephritis type I MCGN. I. A comparative study.
Wagrowska-Danilewicz M; Danilewicz M
J Nephrol; 1998; 11(1):44-9. PubMed ID: 9561485
[TBL] [Abstract][Full Text] [Related]
40. Brucella glomerulonephritis: review of the literature and report on the first patient with brucellosis and mesangiocapillary glomerulonephritis.
Altiparmak MR; Pamuk GE; Pamuk ON; Tabak F
Scand J Infect Dis; 2002; 34(6):477-80. PubMed ID: 12160181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
